Analysts predict slower initial sales for the Alzheimer’s medication Leqembi
Jay Reinstein, an individual suffering from Alzheimer’s, recently underwent a PET scan at MedStar Georgetown University Hospital in Washington, DC on June 20, 2023, after receiving an injection. Image Credit: Michael Robinson Chávez | The Washington Post | Getty Images Analysts predict that sales of the Alzheimer’s drug Leqembi may start off slow due to …